PMC:7289100 / 4898-5107
Annnotations
LitCovid-PD-FMA-UBERON
{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T16","span":{"begin":15,"end":28},"obj":"Body_part"},{"id":"T17","span":{"begin":46,"end":54},"obj":"Body_part"}],"attributes":[{"id":"A16","pred":"fma_id","subj":"T16","obj":"http://purl.org/sig/ont/fma/fma62925"},{"id":"A17","pred":"fma_id","subj":"T17","obj":"http://purl.org/sig/ont/fma/fma62851"}],"text":"bodies against glycoproteins expressed on the platelet surface. The clinical course is often acute, and life-threatening events may occur especially in children, with 52% of pediatric patients recovering eithe"}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T53","span":{"begin":167,"end":169},"obj":"http://purl.obolibrary.org/obo/CLO_0001407"}],"text":"bodies against glycoproteins expressed on the platelet surface. The clinical course is often acute, and life-threatening events may occur especially in children, with 52% of pediatric patients recovering eithe"}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T10","span":{"begin":15,"end":28},"obj":"Chemical"}],"attributes":[{"id":"A10","pred":"chebi_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/CHEBI_17089"}],"text":"bodies against glycoproteins expressed on the platelet surface. The clinical course is often acute, and life-threatening events may occur especially in children, with 52% of pediatric patients recovering eithe"}
LitCovid-PMC-OGER-BB
{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T95","span":{"begin":15,"end":28},"obj":"CHEBI:17089;BV_11;CHEBI:17089"},{"id":"T96","span":{"begin":29,"end":38},"obj":"GO:0010467"},{"id":"T97","span":{"begin":46,"end":54},"obj":"CL:0000233"},{"id":"T98","span":{"begin":55,"end":62},"obj":"GO:0009986"},{"id":"T99","span":{"begin":104,"end":108},"obj":"UBERON:0000104"},{"id":"T25574","span":{"begin":15,"end":28},"obj":"CHEBI:17089;BV_11;CHEBI:17089"},{"id":"T66959","span":{"begin":29,"end":38},"obj":"GO:0010467"},{"id":"T99761","span":{"begin":46,"end":54},"obj":"CL:0000233"},{"id":"T98484","span":{"begin":55,"end":62},"obj":"GO:0009986"},{"id":"T47101","span":{"begin":104,"end":108},"obj":"UBERON:0000104"}],"text":"bodies against glycoproteins expressed on the platelet surface. The clinical course is often acute, and life-threatening events may occur especially in children, with 52% of pediatric patients recovering eithe"}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"185","span":{"begin":152,"end":160},"obj":"Species"},{"id":"186","span":{"begin":184,"end":192},"obj":"Species"}],"attributes":[{"id":"A185","pred":"tao:has_database_id","subj":"185","obj":"Tax:9606"},{"id":"A186","pred":"tao:has_database_id","subj":"186","obj":"Tax:9606"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"bodies against glycoproteins expressed on the platelet surface. The clinical course is often acute, and life-threatening events may occur especially in children, with 52% of pediatric patients recovering eithe"}